Modulation of memory, reinforcement and anxiety parameters by intra- amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s

Peptides

Volumn 19, Issue 1, 1998, Pages 27-37

  Huston, J P ^a   Schildein, S ^a   Gerhardt, P ^a   Privou, C ^a   Fink, H ^b   Hasenohrl R U ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Amygdala; Boc CCK 4; CCK 8s; Cholecystokinin (CCK); Conditioned place preference; Elevated plus maze; Inhibitory avoidance

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE DERIVATIVE; TETRAGASTRIN DERIVATIVE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; MALE; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

AMYGDALA; ANIMALS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); MALE; MAZE LEARNING; MEMORY; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY); SINCALIDE; TETRAGASTRIN;

EID: 0031952284     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00270-2     Document Type: Article

References (81)

1. Belcheva I., Belcheva S., Petkov V. V., Petkov V. D. Asymmetry in behavioral responses to cholecystokinin microinjected into the rat nucleus accumbens and amygdala. Neuropharmacology. 33:1994;995-1002.
2. Bradwejn J., Koszycki D. The cholecystokinin hypothesis of anxiety and panic disorders. Ann. NY Acad. Sci. 713:1994;273-282.
3. Cahill L., McGaugh J. L. Amygdaloid complex lesions differentially affect retention of tasks using appetitive and aversive reinforcement. Behav. Neurosci. 104:1990;532-543.
4. Carey R. J. Post-trial hormonal treatment effects Memory modulation or perceptual distortion? J. Neurosci. Methods. 22:1987;27-30.
5. Crawley J. N., Corwin R. L. Biological actions of cholecystokinin. Peptides. 15:1994;731-755.
6. Cruz A. P., Frein F., Graeff F. G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-176.
7. Davis M. Animal models of anxiety based on classical conditioning The conditioned emotional response (CER) and the fear-potentiated startle effect . Pharmacol. Ther. 47:1990;147-165.
8. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 15:1992;353-375.
9. Davis M. The role of the amygdala in emotional learning. Int. Rev. Neurobiol. 36:1994;225-266.
10. Derrien M., Dauge V., Blommaert A., Roques B. P. The selective CCK-B agonist, BC 264, impairs socially reinforced memory in the three-panel runway test in rats. Behav. Brain Res. 65:1994;139-146.
11. Derrien M., McCort-Tranchepain I., Ducos B., Roques B. P., Durieux C. Heterogeneity of CCK-B receptors involved in animal models of anxiety. Pharmacol. Biochem. Behav. 49:1994;133-141.
12. Emson, P. C.; Marley, P. D. Cholecystokinin and vasoactive intestinal polypeptide. In: Iversen, L. L.; Iversen, S. D.; Snyder, S. H., Eds. Handbook of psychopharmacology, vol. 16. New York: Plenum Press; 1983:255-278.
13. Fekete M., Lengyel A., Hegedüs B., Penke B., Zarandy M., Toth G., Telegdy G. Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats. Eur. J. Pharmacol. 98:1984;79-91.
14. Fink H., Ott T. CCK-8 modulates locomotor activity of SKF 38393-treated rats. Biogenic Amines. 8:1992;237-243.
15. 2 receptor agonist-induced hypermotility in the nucleus accumbens. Brain Res. Bull. 26:1991;437-440.
16. Flood J. F., Morley J. E. Cholecystokinin receptors mediate enhanced memory retention produced by feeding and gastrointestinal peptides. Peptides. 10:1989;809-813.
17. Flood J. F., Silver A. J., Morley J. E. Do peptide-induced changes in feeding occur because of changes in motivation to eat? Peptides. 11:1990;265-270.
18. Flood J. F., Garland J. S., Morley J. E. Evidence that cholecystokinin-enhanced retention is mediated by changes in opioid activity in the amygdala. Brain Res. 585:1992;94-104.
19. Flood J. F., Merbaum M. O., Morley J. E. The memory enhancing effects of cholecystokinin octapeptide are dependent on an intact stria terminalis. Neurobiol. Learn. Mem. 64:1995;139-145.
20. 3H]pentagastrin. Peptides. 4:1983;755-762.
21. Gerhardt P., Hasenöhrl R. U., Huston J. P. Enhanced learning produced by injection of neurokinin substance P into the region of the nucleus basalis magnocellularis Mediation by the N-terminal sequence . Exp. Neurol. 118:1992;302-308.
22. Gerhardt P., Voits M., Fink H., Huston J. P. Evidence for mnemotropic action of cholecystokinin fragments Boc-CCK-4 and CCK-8s. Peptides. 15:1994;689-697.
23. Graeff F. G., Silveira M. C., Nogueira R. L., Audi E. A., Oliveira R. M. Role of the amygdala and periaqueductal gray in anxiety and panic. Behav. Brain Res. 58:1993;123-131.
24. Hadjivanova C., Petkov V. V., Kehayov R., Martinez J. Behavioral effects of two cholecystokinin analogues JMV 236 and JMV 179 . Neuropeptides. 27:1994;163-167.
25. Harro J., Vasar E. Evidence that CCKB receptors mediate the regulation of exploratory behavior in the rat. Eur. J. Pharmacol. 193:1991;379-381.
26. Harro J., Oreland L. Cholecystokinin receptors and memory A radial maze study . Pharmacol. Biochem. Behav. 44:1993;509-517.
27. Harro J., Vasar E., Bradwejn J. CCK in animal and human research on anxiety. Trends Pharmacol. Sci. 14:1993;244-249.
28. Hasenöhrl R. U., Oitzl M. S., Huston J. P. Conditioned place preference in the corral A procedure for measuring reinforcing properties of drugs . J. Neurosci. Methods. 30:1989;141-146.
29. Hasenöhrl R. U., Gerhardt P., Huston J. P. Substance P enhancement of inhibitory avoidance learning Mediation by the N-terminal sequence . Peptides. 11:1990;163-167.
30. Hasenöhrl R. U., Gerhardt P., Huston J. P. Positively reinforcing effects of the neurokinin substance P in the basal forebrain Mediation by its C-terminal sequence . Exp. Neurol. 115:1992;282-291.
31. Hasenöhrl R. U., Nichau Ch, Frisch Ch, De Souza Silva M. A., Huston J. P., Mattern C. M., Häcker R. Anxiolytic-like effect of combined extracts of zingiber officinale and ginkgo biloba in the elevated plus-maze. Pharmacol. Biochem. Behav. 53:1996;271-275.
32. 3 receptor antagonist ondansetron on hypothalamic self-stimulation in rats and its interaction with the CCK analogue caerulein. Neurosci. Lett. 140:1992;16-18.
33. Higgins G. A., Nguyen P., Sellers E. M. Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists. Brain Res. 572:1992;208-215.
34. Hill D. R., Campbell N. J., Shaw T. M., Woodruff G. N. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J. Neurosci. 7:1987;2967-2976.
35. Hirosue Y., Inui A., Miura M., Nakajima M., Okita M., Himori N., Baba S., Kasuga M. Effects of CCK antagonists on CCK-induced suppression of locomotor activity in mice. Peptides. 13:1992;155-157.
36. Hökfelt T., Rehfeld J. F., Skirboll L., Ivemark B., Goldstein M., Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature. 285:1980;476-478.
37. Hökfelt T., Herrera-Marschitz M., Seroogy K., Ju G., Staines W. A., Holets V., Schalling M., Ungerstedt U., Post C., Rehfeld J. F. et al. Immunohistochemical studies on cholecystokinin (CCK)-immunoreactive neurons in the rat using sequence specific antisera and with special reference to the caudate nucleus and primary sensory neurons. J. Chem. Neuroanat. 1:1988;11-51.
38. Holland P. C., Gallagher M. Effects of amygdala central nucleus lesions on blocking and unblocking. Behav. Neurosci. 107:1993;235-245.
39. Holland P. C., Gallagher M. Amygdala central nucleus lesions disrupt increments, but not decrements, in conditioned stimulus processing. Behav. Neurosci. 107:1993;246-253.
40. Hsiao S., Katsuura G., Itoh S. Cholecystokinin tetrapeptide, proglumide and open-field behavior in rats. Life Sci. 34:1984;2165-2168.
41. Hughes J., Boden P., Costall B., Domeney A., Kelly E., Horwell D. C., Hunter J. C., Pinnock R. D., Woodruff G. N. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. USA. 87:1990;6728-6732.
42. Huston, J. P.; Stäubli, U. Substance P and its effects on learning and memory. In: Martinez, J. L.; Jensen, R. A.; Messing, R. B.; Rigter, H.; McGaugh, J. L., Eds. Endogenous peptides and learning and memory processes. New York: Academic Press; 1981:521-540.
43. Huston J. P., Oitzl M. S. The relationship between reinforcement and memory Parallels in the rewarding and mnemonic effects of the neuropeptide substance P . Neurosci. Biobehav. Rev. 13:1989;171-180.
44. Itoh S., Katsuura G., Takashima A. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats. Can. J. Physiol. Pharmacol. 65:1987;2260-2264.
45. Iwata J., Chida K., LeDoux J. E. Cardiovascular responses elicited by stimulation of neurons in the central amygdaloid nucleus in awake but not anesthetized rats resemble conditioned emotional responses. Brain Res. 418:1987;183-188.
46. Kaada, B. R. Stimulation and ablation of the amygdaloid complex with reference to functional representations. In: Eleftheriou, B. E., Ed. The neurobiology of the amygdala. New York: Plenum Press; 1972:205-281.
47. Katsuura G., Itoh S. Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats. Peptides. 7:1986;809-814.
48. Katsuura G., Hsiao S., Itoh S. Blocking of cholecystokinin octapeptide behavioral effects by proglumide. Peptides. 5:1984;529-534.
49. Koob, G. F. Neuropeptides and memory. In: Iversen, L. L.; Iversen, S. D.; Snyder, S. H., Eds. Handbook of psychopharmacology, vol. 19. New York: Plenum Press; 1987:531-573.
50. Krauth, J. Distribution-free statistics: An application-oriented approach. Amsterdam: Elsevier; 1988.
51. Larsson L.-I., Rehfeld J. F. Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res. 165:1979;201-218.
52. LeDoux, J. E. Emotion and the amygdala. In: Aggleton, J. P., Ed. The amygdala. Neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss, Inc.; 1992:339-351.
53. LeDoux J. E., Iwata J., Cicchetti P., Reis D. J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 8:1988;2517-2529.
54. Lemaire M., Bohme G. A., Piot O., Roques B. P., Blanchard J. C. CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats. Psychopharmacology. 115:1994;435-440.
55. Marley P. D., Rehfeld J. F., Emson P. C. Distribution and chromatographic characterisation of gastrin and cholecystokinin in the rat central nervous system. J. Neurochem. 42:1984;1523-1535.
56. McGaugh J. L., Introini-Collison I. B., Cahill L. F., Castellano C., Dalmaz C., Parent M. B., Williams C. L. Neuromodulatory systems and memory storage Role of the amygdala . Behav. Brain Res. 58:1993;81-90.
57. Meziane H., Devigne C., Tramu G., Soumireu-Mourat B. Effects of anti-CCK-8 antiserum on acquisition and retrieval by mice in an appetitive task. Peptides. 14:1993;67-73.
58. Myers R. D. Injection of solutions into cerebral tissue Relation between volume and diffusion . Physiol. Behav. 1:1966;171-174.
59. Nagel J. A., Huston J. P. Enhanced inhibitory avoidance learning produced by post-trial injections of substance P into the basal forebrain. Behav. Neural Biol. 49:1988;374-385.
60. 125I-Bolton-Hunter-CCK8. Peptides. 10:1989;265-274.
61. O'Neill M. F., Dourish C. T., Iversen S. D. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365, 260. Eur. J. Pharmacol. 193:1991;203-208.
62. Pavlasevic S., Bednar I., Qureshi G. A., Sodersten P. Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety. Neuroreport. 5:1993;225-228.
63. Paxinos G., Watson C. The rat brain in stereotaxic coordinates (2nd ed. ). 1986;Academic Press, New York.
64. Pellow S., Chopin P., File S. E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
65. Pettit H. O., Mueller K. Infusions of cholecystokinin octapeptide into the ventral tegmental area potentiate amphetamine conditioned place preferences. Psychopharmacology. 99:1989;423-426.
66. Phillips G. D., Le-Noury J., Wolterink G., Donselaar-Wolterink I., Robbins T. W., Everitt B. J. Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement. Behav. Brain Res. 55:1993;223-231.
67. Pratt J. A., Brett R. R. The benzodiazepine receptor inverse agonist FG 7142 induces cholecystokinin gene expression in rat brain. Neurosci. Lett. 184:1995;197-200.
68. Rehfeld J. F. Neuronal cholecystokinin One or multiple transmitters? J. Neurochem. 44:1985;1-10.
69. Rex A., Fink H., Marsden C. A. Effects of Boc-CCK-4 and L 365,260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze. Neuropharmacology. 33:1994;559-565.
70. Rex A., Barth T., Voigt J.-P., Domeney A. M., Fink H. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety. Neurosci. Lett. 172:1994;139-142.
71. Rodgers R. J., Johnson N. J. Cholecystokinin and anxiety Promises and pitfalls . Crit. Rev. Neurobiol. 9:1995;345-369.
72. Rompre P. P., Boye S. M. Opposite effects of mesencephalic microinjections of cholecystokinin octapeptide and neurotensin-(1-13) on brain stimulation reward. Eur. J. Pharmacol. 232:1993;299-303.
73. Singh L., Field M. J., Hughes J., Menzies R., Oles R. J., Vass C. A., Woodruff G. N. The behavioral properties of CI-988, a selective cholecystokinin B receptor antagonist. Br. J. Pharmacol. 104:1991;239-245.
74. Spiegler B. J., Mishkin M. Evidence for the sequential participation of inferior temporal cortex and amygdala in the acquisition of stimulus-reward associations. Behav. Brain Res. 3:1981;303-317.
75. Stäubli U., Huston J. P. Up-hill avoidance A new passive-avoidance task . Physiol. Behav. 22:1979;775-776.
76. Swerdlow N. R., van der Kooy D., Koob G. F., Wenger J. R. Cholecystokinin produces conditioned place aversions, not place preferences, in food deprived rats Evidence against involvement in satiety . Life Sci. 32:1983;2087-2093.
77. Tomaz C., Kickinson-Anson H., McGaugh J. L., Souza-Silva M. A., Viana M. B., Graeff F. G. Localization in the amygdala of the amnestic action of diazepam on emotional memory. Behav. Brain Res. 58:1993;99-105.
78. Vanderhaeghen J. J., Lotstra F., De Mey J., Gilles C. Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. Proc. Natl. Acad. Sci. USA. 77:1980;1190-1194.
79. Venault P., Chapouthier G., de-Carvalho L. PP., Simiand J., Moore M., Dodd R. H., Rossier J. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature. 321:1986;864-866.
80. Wank S. A., Harkins R., Jensen R. T., Shapira H. ; de-Weerth, A.; Slattery, T. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc. Natl. Acad. Sci. USA. 89:1992;3125-3129.
81. Wank S. A., Pisegna J. R. ; de-Weerth, A. Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc. Natl. Acad. Sci. USA. 89:1992;8691-8695.